Picture Berlin Partner Hotspot for Startups 650x80px
Document › Details

ThromboGenics N.V.. (3/15/18). "Press Release: ThromboGenics Business Update – FY 2017". Leuven.

Organisations Organisation ThromboGenics N.V. (Euronext Brussels: THR)
  Today Oxurion N.V. (Euronext Brussels: OXUR)
  Group Oxurion (Group)
  Organisation 2 Oncurious N.V.
  Group Oxurion (Group)
Products Product Jetrea®
  Product 2 THR-317 (ThromboGenics)
Persons Person De Haes, Patrik (ThromboGenics 200808– CEO before Roche Diagnostics)
  Person 2 Vangeersdaele, Vinciane (ThromboGenics 201711– CCO before Novartis Ophthalmics)

Record changed: 2018-09-25


Picture EBD Group Connector Personal Networking in Life Sciences 650x80

More documents for Oxurion (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture EBD Group Global Partnering Four Events One Price 650x80

» top